News | November 06, 2006

McKesson Will Buy Per-Se in ‘07

San Francisco-based McKesson announced it has agreed to purchase Per-Se Technologies, Alpharetta, Ga., in a deal worth $1.8 billion. The purchase is expected to close in the first quarter of 2007 if it meets regulatory approval.

McKesson’s strength will be further extended in the pharmacy software systems arena, and the acquisition also gives the company a strong presence in the small physician-office practice-management software systems market, where Per-Se had obtained a dominant position following its August 2005 acquisition of the physician, hospital and retail pharmacy business of NDC Health for a reported $644 million.

McKesson is one of the three largest pharmaceutical wholesalers in the U.S., with revenue of nearly $22.4 billion in its fiscal year second quarter ended Sept. 30.


Additional Content

News | Pharmaceuticals

July 16, 2026 — Merck has received U.S. Food and Drug Administration (FDA) approval for Lipfendra (enlicitide) tablets ...

Home July 16, 2026
Home
News | Pharmaceuticals

Jan. 27, 2026 — Cytokinetics, Inc. has announced that Myqorzo (aficamten) is now available for prescription in 5 mg, 10 ...

Home January 28, 2026
Home
News | Pharmaceuticals

Nov. 19, 2025 — Promising results from a pivotal Phase 3 clinical trial of an investigational heart-attack drug were ...

Home November 19, 2025
Home
News | Pharmaceuticals

Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...

Home September 25, 2025
Home
News | Pharmaceuticals

Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug ...

Home September 23, 2025
Home
Subscribe Now